The outcome of patients with rheumatoid arthritis: a cross-sectional study-Reference-Cited by-同舟云学术

The outcome of patients with rheumatoid arthritis: a cross-sectional study

Published:2019 Issue: Volume: Page:5-9
ISSN:1658-7820
Container-title:International Journal of Medicine in Developing Countries
language:
Short-container-title:IJMDC

Author:

Algohani Khaled,Althobaiti Muhannad,Alshammari Sanad,Alnahari Fahad,Aldahhasi Ali,Habshan Feras

Publisher

Discover STM Publishing Ltd.

Link

https://www.ejmanager.com/fulltextpdf.php?mno=21086

Reference21 articles.

1. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492-509. https://doi.org/10.1136/annrheumdis-2013-204573

2. Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2014;73(3):516-28. https://doi.org/10.1136/annrheumdis-2013-204577

3. Gawrysiak W, Skrypnik K, Suliburska J, Skrypnik D, Bogdanski P. Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. Przegl Lek. 2017;74(4):179-82.

4. van Vollenhoven RF, Wax S, Li Y, Tak PP. Safety and efficacy of atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled pilot trial. Arth Rheumatol. 2015;67(11):2828-36. https://doi.org/10.1002/art.39262

5. Torres Suarez E, Pinheiro R, Schrage N. Complications in the treatment of ocular surface squamous neoplasia with interferon alpha2b in rheumatoid arthritis. Ophthalmologe. 2017;114(2):155-8. https://doi.org/10.1007/s00347-016-0292-y